Explore evidence

15.68 scorePost-intervention mean BSE practice scores in the modern method group increased to 15.68 ± 3.12.

Nigeriacancer du seinpublished 2024BMC cancerPubMeddocument of 11 observations

7.25 %Middle-aged individuals had 7.25% knowledge about antibiotics as a breast cancer risk factor.

Nigeriacancer du seinpublished 2024JCO global oncologyPubMeddocument of 12 observations

5.2 %Luminal B subtype was found in 5.2% of cases.

Nigeriacancer du seinpublished 2024West African journal of medicinePubMeddocument of 13 observations

1.9 %Medullary carcinoma accounted for 14 (1.9%) of the 761 breast cancer patients.

Nigeriacancer du sein · medullary carcinomaobserved 2008 to 2012published 2019The Pan African medical journalPubMeddocument of 7 observations

0.036 p_valueTP53 was significantly associated with breast cancer (five cases, zero controls; P = .036).

Nigeriacancer du seinpublished 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 14 observations

49 %Among 436 treatment-naïve Nigerian breast cancer patients, 49% were classified as having low tumor-infiltrating lymphocytes (TILs) (< 10%).

Nigeriacancer du seinpublished 2026Breast cancer research and treatmentPubMeddocument of 14 observations

67.2 %In the MEND case-control study, 67.2% of Nigerian breast cancer cases were grade 2.

Nigeriacancer du seinpublished 2026Breast cancer research and treatmentPubMeddocument of 10 observations

65 %Fatigue was reported by 65% of breast cancer patients undergoing chemotherapy in Delta State, Nigeria.

Nigeriacancer du sein · fatiguepublished 2026The Pan African medical journalPubMeddocument of 5 observations

12 %Other drugs contributed 12% of the total costs for breast cancer care.

Nigeriacancer du seinpublished 2025American journal of surgeryPubMeddocument of 13 observations

Serum adiponectin and HDL levels were lower (p < 0.05) in the breast cancer patients relative to control subjects.

Nigeriacancer du seinpublished 2025Breast cancer (Tokyo, Japan)PubMeddocument of 8 observations

1.6 score_unitsThe clinical management module showed a mean knowledge score change of 1.6 (95% CI, 1.2 to 2.1) among Nigerian health care providers.

Nigeriacancer du seinpublished 2026JCO global oncologyPubMeddocument of 5 observations

43.6 %At a median follow-up period of 20.5 months, the overall survival among patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018 was 43.6% (95% CI: 37.7 to 49.5).

Nigeriacancer du seinobserved 2010–2018published 2021International journal of cancerPubMeddocument of 12 observations

76.2 %Seventy-six point two percent of the participants reported financial hardship as a result of breast cancer treatment costs.

Nigeriacancer du seinpublished 2023African journal of reproductive healthPubMeddocument of 4 observations

6.44 scorePre-intervention mean BSE practice scores in the modern method group were 6.44 ± 2.75.

Nigeriacancer du seinpublished 2024BMC cancerPubMeddocument of 11 observations

1,686 individualsA total of 1686 women were included in the main analyses, of whom 996 were cases and 690 were controls.

Nigeriacancer du seinpublished 2025JAMA network openPubMeddocument of 6 observations

14 %Cost precluded surgery in 14% of patients with resectable disease.

Nigeriacancer du seinpublished 2022The Pan African medical journalPubMeddocument of 9 observations

31.8 scoreThe pre-intervention overall symptom domain score was 31.8 ± 10.89 for the intervention group.

Nigeriacancer du seinpublished 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 8 observations

74.4 %Sixty-one (74.4%) of the 82 breast cancer patients were locally advanced at presentation.

Nigeriacancer du seinobserved 2011–2015published 2020The Pan African medical journalPubMeddocument of 16 observations

10.5 yearsIndigenous African patients in Nigeria had a 10.5-year younger age at diagnosis of breast cancer compared to The Cancer Genome Atlas cohort.

Nigeriacancer du seinpublished 2020Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatieurope_pmcdocument of 2 observationsDOI 10.1101/2020.10.28.359240

51.2 scoreThe post-intervention overall generic functional domain score was 51.2 ± 17.8 for the control group.

Nigeriacancer du seinpublished 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument of 8 observations

7 %Surgery contributed 7% of the total costs for breast cancer care.

Nigeriacancer du seinpublished 2025American journal of surgeryPubMeddocument of 13 observations

17,992 USDAmong 130 breast cancer patients who underwent multiple treatment modalities, the average out-of-pocket cost was $17992.

Nigeriacancer du seinpublished 2025American journal of surgeryPubMeddocument of 13 observations

1.9 %1.9% of the respondents had good knowledge of the risk factors and symptoms of breast cancer.

Nigeriacancer du seinpublished 2024West African journal of medicinePubMeddocument of 7 observations

56.76 %Benign lesions were predominant (56.76%) among the 3,263 breast histopathology records.

Nigeriacancer du seinobserved 2015 to 2023published 2025Scientific reportsPubMeddocument of 12 observations

49 yearsThe average age of patients with histologically confirmed breast cancer was 49 years.

Nigeriacancer du seinpublished 2024West African journal of medicinePubMeddocument of 13 observations